These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 29260654)
1. Impact Evaluation of Seasonal Malaria Chemoprevention under Routine Program Implementation: A Quasi-Experimental Study in Burkina Faso. Druetz T; Corneau-Tremblay N; Millogo T; Kouanda S; Ly A; Bicaba A; Haddad S Am J Trop Med Hyg; 2018 Feb; 98(2):524-533. PubMed ID: 29260654 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali. Cairns ME; Sagara I; Zongo I; Kuepfer I; Thera I; Nikiema F; Diarra M; Yerbanga SR; Barry A; Tapily A; Coumare S; Milligan P; Tinto H; Ouédraogo JB; Chandramohan D; Greenwood B; Djimde A; Dicko A PLoS Med; 2020 Aug; 17(8):e1003214. PubMed ID: 32822362 [TBL] [Abstract][Full Text] [Related]
3. Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial. Moreno M; Barry A; Gmeiner M; Yaro JB; Sermé SS; Byrne I; Ramjith J; Ouedraogo A; Soulama I; Grignard L; Soremekun S; Koele S; Ter Heine R; Ouedraogo AZ; Sawadogo J; Sanogo E; Ouedraogo IN; Hien D; Sirima SB; Bradley J; Bousema T; Drakeley C; Tiono AB BMJ Open; 2024 Mar; 14(3):e081682. PubMed ID: 38479748 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. ACCESS-SMC Partnership Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936 [TBL] [Abstract][Full Text] [Related]
6. Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria. de Cola MA; Sawadogo B; Richardson S; Ibinaiye T; Traoré A; Compaoré CS; Oguoma C; Oresanya O; Tougri G; Rassi C; Roca-Feltrer A; Walker P; Okell LC BMJ Glob Health; 2022 May; 7(5):. PubMed ID: 35589153 [TBL] [Abstract][Full Text] [Related]
7. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali. Diawara F; Steinhardt LC; Mahamar A; Traore T; Kone DT; Diawara H; Kamate B; Kone D; Diallo M; Sadou A; Mihigo J; Sagara I; Djimde AA; Eckert E; Dicko A Malar J; 2017 Aug; 16(1):325. PubMed ID: 28797263 [TBL] [Abstract][Full Text] [Related]
8. Delivery of seasonal malaria chemoprevention with enhanced infection prevention and control measures during the COVID-19 pandemic in Nigeria, Burkina Faso and Chad: a cross-sectional study. Ward C; Phillips A; Oresanya O; Olisenekwu G; Arogunade E; Moukénet A; Beakgoubé H; De Paul Allambademel V; Compaoré CS; Traoré A; Ouedraogo JB; Compaoré YD; Zongo I; Donovan L; Decola MA; Smith H; Baker K Malar J; 2022 Mar; 21(1):103. PubMed ID: 35331248 [TBL] [Abstract][Full Text] [Related]
9. Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso. Traore A; Donovan L; Sawadogo B; Ward C; Smith H; Rassi C; Counihan H; Johansson J; Richardson S; Savadogo JR; Baker K BMC Public Health; 2022 Mar; 22(1):442. PubMed ID: 35247990 [TBL] [Abstract][Full Text] [Related]
10. Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso. Kirakoya-Samadoulougou F; De Brouwere V; Fokam AF; Ouédraogo M; Yé Y Malar J; 2022 May; 21(1):143. PubMed ID: 35524310 [TBL] [Abstract][Full Text] [Related]
11. [Monitoring of adverse drug reactions during seasonal malaria chemoprevention campaigns in children aged 3–59 months in Burkina Faso]. Ouoba J; Lankoandé-Haro S; Fofana S; Nacoulma AP; Kaboré L; Sombié I; Rouamba T; Kirakoya-Samadoulougou F Sante Publique; 2024 Jan; 35(5):121-132. PubMed ID: 38172043 [TBL] [Abstract][Full Text] [Related]
12. Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso. Sondo P; Rouamba T; Tahita MC; Derra K; Kabore B; Tibiri YNG; Kabore HALF; Hien SF; Ouedraogo F; Kazienga A; Ilboudo H; Rouamba E; Lefevre T; Tinto H PLoS One; 2023; 18(6):e0287210. PubMed ID: 37363896 [TBL] [Abstract][Full Text] [Related]
14. Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy'Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT). Sondo P; Tahita MC; Rouamba T; Derra K; Kaboré B; Compaoré CS; Ouédraogo F; Rouamba E; Ilboudo H; Bambara EA; Nana M; Sawadogo EY; Sorgho H; Somé AM; Valéa I; Dahal P; Traoré/Coulibaly M; Tinto H Trials; 2021 May; 22(1):360. PubMed ID: 34030705 [TBL] [Abstract][Full Text] [Related]
15. Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention. Yaro JB; Tiono AB; Ouedraogo A; Lambert B; Ouedraogo ZA; Diarra A; Traore A; Lankouande M; Soulama I; Sanou A; Worrall E; Agboraw E; Sagnon N; Ranson H; Churcher TS; Lindsay SW; Wilson AL Sci Rep; 2022 Jan; 12(1):1402. PubMed ID: 35082312 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso. Compaoré R; Yameogo MWE; Millogo T; Tougri H; Kouanda S PLoS One; 2017; 12(11):e0187460. PubMed ID: 29186137 [TBL] [Abstract][Full Text] [Related]
17. Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: a qualitative exploration of caregivers and community distributors' perspectives. Lasmi K; Elimian K; Donovan L; Tounaikok N; Traoré A; Gils T; Rassi C; Marasciulo M; Richardson S; Tougri G; Diar MSI; Baker K Malar J; 2024 Jul; 23(1):216. PubMed ID: 39030554 [TBL] [Abstract][Full Text] [Related]